A5072482236- Venous Thromboembolism Diagnosis and Management
- Studies on Chitinases and Chitosanases
- Acute Myocardial Infarction Research
- Glycosylation and Glycoproteins Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Lysosomal Storage Disorders Research
Central South University
2024
General Hospital of Shenyang Military Region
2021
Mucopolysaccharidosis type I (MPS I) is a lysosomal storage disease caused by the deficiency of enzyme α-l-iduronidase (IDUA), typically leading to devastating secondary pathophysiological cascades. Due irreversible nature disease's progression, early diagnosis and interventional treatment has become particularly crucial. Considering fact that serum urine are most commonly used specimens in clinical practice for detection, we conducted an analysis identify differential protein profile MPS...
To observe the efficacy and safety of bivalirudin use in Chinese patients with coronary heart disease (CHD) during peri-percutaneous intervention(PCI) period.A total 3 271 who underwent PCI received periprocedural treatment between July 2013 October 2015 from 88 centers China were involved this study. The primary outcome was 30-day net adverse clinical events (NACE a composite major cardiac or cerebral (MACE, all-cause death, reinfarction, urgent target vessel revascularization, stroke)...
Objective: To compare the efficacy and safety of ticagrelor clopidogrel in elderly Chinese patients with acute coronary syndrome (ACS) underwent percutaneous intervention (PCI) real world. Methods: This study is a post-hoc analysis single center, retrospective cohort study. Between March 2016 2018, (age≥65) ACS who PCI General Hospital Northern Theater Command were included The grouped according to P2Y12 receptor inhibitor. primary endpoints this ischemic events during 2-year follow-up,...